Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Prednisone for Recurrent Pregnancy Loss
NCT04558268Phase 3Unknown
- Sponsor
- Soroka University Medical Center
- Start
- Dec 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone in recurrent pregnancy loss (RPL), sponsored by Soroka University Medical Center. Status: unknown.
02
Drugs
prednisone
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT04558268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558268.